BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Aminophylline readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Aminophylline\, from ClinicalTrials.gov e
 stimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07617948-3742@assetmemo.bio
DTSTAMP:20261121T004945Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:Aminophylline: Phase 2 readout est. (NCT07617948)
DESCRIPTION:Aminophylline\, phase 2.\nStudy: Intravesical Aminophylline for
  Urgent Ureteral Stenting in Acute Calculous Anuria\nEstimated primary com
 pletion: March 2027. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 aminophylline#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07617948
URL:https://assetmemo.bio/drug/aminophylline#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07617896-3742@assetmemo.bio
DTSTAMP:20261121T004945Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Aminophylline: Phase 2 readout est. (NCT07617896)
DESCRIPTION:Aminophylline\, phase 2.\nStudy: Intravesical Aminophylline to 
 Facilitate Ureteroscopic Access in Children With Distal Ureteral Stones.\n
 Estimated primary completion: April 2027. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/aminophylline#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07617896
URL:https://assetmemo.bio/drug/aminophylline#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07623876-3742@assetmemo.bio
DTSTAMP:20261121T004945Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Aminophylline: Phase 2 readout est. (NCT07623876)
DESCRIPTION:Aminophylline\, phase 2.\nStudy: Tamsulosin and Intraureteral A
 minophylline for Ureteral Access During RIRS\nEstimated primary completion
 : April 2027. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/aminoph
 ylline#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07623876
URL:https://assetmemo.bio/drug/aminophylline#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06728943-3742@assetmemo.bio
DTSTAMP:20261121T004945Z
DTSTART;VALUE=DATE:20281201
DTEND;VALUE=DATE:20281202
SUMMARY:Aminophylline: Phase na readout est. (NCT06728943)
DESCRIPTION:Aminophylline\, phase na.\nStudy: Efficacy of Intra-Ureteric Am
 inophylline Installation After Failed Stone Accessibility by Semi-rigid Ur
 eteroscopy. Prospective Trial\nEstimated primary completion: 1 December 20
 28. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/aminophylline#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0672894
 3
URL:https://assetmemo.bio/drug/aminophylline#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
